Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Globe Newswire•02/11/2026•08:00 ET
0
Key Highlights
- ➤Vera Therapeutics (VERA) management to join Guggenheim healthcare conference fireside chat
- ➤Fireside chat scheduled November 10, 2026, at 11:30 AM ET
- ➤Management will hold one-on-one investor meetings during the conference
- ➤TRUTAKNA is Vera Therapeutics’ flagship commercial product
BRISBANE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced that the Company’s management team will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference, which is taking place in Boston, MA from November 9-11, 2026. The management team will also participate in one-on-one investor meetings.
Fireside Chat Details: Date: Tuesday, November 10, 2026 Time: 11:30 AM ET Webcast: https://event.summitcast.com/view/oVDtKqmPn2tPc7VV7WsLAC/VAEZkbjVkcydrQYaGzVnEF
Get started
Create a free account to read the full story.